Skip to content

Clinical trials

Phase 2 Esophageal Neoplasms trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Esophageal Neoplasms Phase: Phase 2 Country / region: Germany Clear all

14 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20051
20081
20101
20111
20141
20182
20201
20211
20231
20243

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed7
Active, not recruiting2
Recruiting2
Not yet recruiting1
Terminated1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AIO-Studien-gGmbH3
Charite University, Berlin, Germany2
AstraZeneca1
CONKO-Studiengruppe1
Daiichi Sankyo1
Merck KGaA, Darmstadt, Germany1
Merck Sharp & Dohme LLC1
National Center for Tumor Diseases, Heidelberg1
Taiho Oncology, Inc.1
University Hospital Heidelberg1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Esophageal Neoplasms14
Stomach Neoplasms7
Pancreatic Neoplasms3
Uterine Cervical Neoplasms3
Adenocarcinoma2
Endometrial Neoplasms2
Ovarian Neoplasms2
Prostatic Neoplasms2
Urinary Bladder Neoplasms2
Anus Neoplasms1

Trials

Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.